Can an enhanced medication information sheet improve drug responsiveness?

This study is assessing whether an enhanced medication information sheet for metoprolol can affect drug responsiveness.

What's involved?

Metoprolol is often taken to treat heart-related conditions such as high blood pressure, heart failure, or an irregular heartbeat. Doctors also prescribe metoprolol to help manage short-term anxiety about specific events.

Participants will take part in a 1-hour in-person study session at the University of Auckland Clinical Research Centre, Grafton Campus. Participants will take a beta-blocker called metoprolol, answer some questionnaires, and participate in a brief stress test to test the medicine's responsiveness.

Participants will receive a $40 Westfield voucher and also have the chance to win an additional $200 prize.

Eligibility criteria

  • Must be 18 years or older
  • Fluent in English
  • Do not have any conditions or take medications for which beta-blockers should not be used

Contact details

Student researcher:

Jasmine Bellerby

Primary supervisor:

Professor Keith Petrie
Phone: 09 373 7599 

Secondary supervisor:

Dr Kate MacKrill

Further information

This study has been approved by the Auckland Health Research Ethics Committee (AHREC) on 19/06/2023 for three years

Reference Number AH25740.